Concepedia

Tolterodine: A Safe and Effective Treatment for Older Patients with Overactive Bladder

James Malone‐Lee, James Bernard Walsh, Marie‐France Maugourd, The Tolterodine in the Elderly Study Group

Journal of the American Geriatrics Society · 2001 · 144 citations · 23 references

DOI

Abstract

Tolterodine (taken for 4 weeks) is safe and shows efficacy, particularly at a dosage of 2 mg bid, in the treatment of older patients with urinary symptoms attributable to overactive bladder.

References

23

EVALUATION OF A MENTAL TEST SCORE FOR ASSESSMENT OF MENTAL IMPAIRMENT IN THE ELDERLY

H. M. HODKINSON · Age and Ageing · 1972 · 1.7K citations

, , +14

Prevalence of urinary incontinence.

Terry Thomas, Kay R. Plymat, J Blannin et al. · BMJ · 1980 · 951 citations · Full text

, , +10

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

Abrams, Freeman, AnderstrÖM et al. · British Journal of Urology · 1998 · 396 citations

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis

Rodney A. Appell · Urology · 1997 · 311 citations

, , +6

Urinary incontinence in the community--analysis of a MORI poll.

J.C. Brocklehurst · BMJ · 1993 · 306 citations · Full text